Skip to content
10-K

Annual Report

Mirum Pharmaceuticals, Inc. MIRM

0001759425-26-000013

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 60.34M sh
Shares Diluted FY 2025 · Dec 31, 2025 50.2M sh
Shares Diluted FY 2025 · Dec 31, 2024 47.52M sh
Shares Diluted FY 2025 · Dec 31, 2023 40.89M sh
Capex FY 2025 · Dec 31, 2025 $954K
Capex FY 2025 · Dec 31, 2024 $993K
Capex FY 2025 · Dec 31, 2023 $109K
Operating Cash Flow FY 2025 · Dec 31, 2025 $55.83M
Operating Cash Flow FY 2025 · Dec 31, 2024 $10.33M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$70.94M
Short Term Investments FY 2025 · Dec 31, 2025 $86.64M
Short Term Investments FY 2025 · Dec 31, 2024 $57.81M
Cash And Equivalents FY 2025 · Dec 31, 2025 $296.68M
Cash And Equivalents FY 2025 · Dec 31, 2024 $222.5M
Stockholders Equity FY 2025 · Dec 31, 2025 $314.69M
Stockholders Equity FY 2025 · Dec 31, 2024 $225.64M
Stockholders Equity FY 2025 · Dec 31, 2023 $248.67M
Stockholders Equity FY 2025 · Dec 31, 2022 $142.04M
Current Liabilities FY 2025 · Dec 31, 2025 $205.8M
Current Liabilities FY 2025 · Dec 31, 2024 $126.55M
Total Liabilities FY 2025 · Dec 31, 2025 $528.12M
Total Liabilities FY 2025 · Dec 31, 2024 $445.11M
Current Assets FY 2025 · Dec 31, 2025 $549.68M
Current Assets FY 2025 · Dec 31, 2024 $392.79M
Total Assets FY 2025 · Dec 31, 2025 $842.81M
Total Assets FY 2025 · Dec 31, 2024 $670.75M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.47
Eps Diluted FY 2025 · Dec 31, 2024 −$1.85
Eps Diluted FY 2025 · Dec 31, 2023 −$4.00
Eps Basic FY 2025 · Dec 31, 2025 −$0.47
Eps Basic FY 2025 · Dec 31, 2024 −$1.85
Eps Basic FY 2025 · Dec 31, 2023 −$4.00
Sga Expense FY 2025 · Dec 31, 2025 $257.03M
Sga Expense FY 2025 · Dec 31, 2024 $202.22M
Sga Expense FY 2025 · Dec 31, 2023 $145.88M
Net Income FY 2025 · Dec 31, 2025 −$23.36M
Net Income FY 2025 · Dec 31, 2024 −$87.94M
Net Income FY 2025 · Dec 31, 2023 −$163.42M
Operating Income FY 2025 · Dec 31, 2025 −$22.14M
Operating Income FY 2025 · Dec 31, 2024 −$87.61M
Operating Income FY 2025 · Dec 31, 2023 −$109.15M
Revenue FY 2025 · Dec 31, 2025 $521.31M
Revenue FY 2025 · Dec 31, 2024 $336.89M
Revenue FY 2025 · Dec 31, 2023 $186.37M